迈瑞医疗传拟赴港二次上市，80后董秘李文楣日薪近3万元

市场资讯2025-07-28

炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！　　瑞财经刘治颖　　据外媒引述知情人士消息，迈瑞医疗（SZ300760）正考虑在香港进行二次上市，预计募集资金规模至少10亿美元（约合78亿港元）。迈瑞医疗已与潜在顾问就股份发售事宜展开初步讨论，相关方案仍在审议阶段。　　针对上述传闻，7月23日，迈瑞医疗回应媒体称：“以官方发布的信息为准”，未予置评。　　迈瑞医疗...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2555865730?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-07-28 18:02","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2555865730","market":"sh","top_or_hot":-1,"title":"迈瑞医疗传拟赴港二次上市，80后董秘李文楣日薪近3万元","media":"市场资讯","content":"<div>\n<p>炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 　　瑞财经 刘治颖\n　　据外媒引述知情人士消息，迈瑞医疗（SZ300760）正考虑在香港进行二次上市，预计募集资金规模至少10亿美元（约合78亿港元）。迈瑞医疗已与潜在顾问就股份发售事宜展开初步讨论，相关方案仍在审议阶段。\n　　针对上述传闻，7月23日，迈瑞医疗回应媒体称：“以官方发布的信息为准”，未予置评。\n　　迈瑞医疗...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/bxjj/2025-07-28/doc-infhzpns1584315.shtml\">网页链接</a>\n\n</div>\n","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>迈瑞医疗传拟赴港二次上市，80后董秘李文楣日薪近3万元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n迈瑞医疗传拟赴港二次上市，80后董秘李文楣日薪近3万元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-28 18:02 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/bxjj/2025-07-28/doc-infhzpns1584315.shtml><strong>市场资讯</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 　　瑞财经 刘治颖\n　　据外媒引述知情人士消息，迈瑞医疗（SZ300760）正考虑在香港进行二次上市，预计募集资金规模至少10亿美元（约合78亿港元）。迈瑞医疗已与潜在顾问就股份发售事宜展开初步讨论，相关方案仍在审议阶段。\n　　针对上述传闻，7月23日，迈瑞医疗回应媒体称：“以官方发布的信息为准”，未予置评。\n　　迈瑞医疗...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/bxjj/2025-07-28/doc-infhzpns1584315.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1023057109.AUD","symbol_name":"BGF CHINA \"A2\" (AUDHDG) ACC","start_time":0,"source_url":"https://finance.sina.com.cn/stock/bxjj/2025-07-28/doc-infhzpns1584315.shtml","article_id":"2555865730","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2555865730","pubTimestamp":1753696920,"columns":[],"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"　　据外媒引述知情人士消息，迈瑞医疗正考虑在香港进行二次上市，预计募集资金规模至少10亿美元。迈瑞医疗已与潜在顾问就股份发售事宜展开初步讨论，相关方案仍在审议阶段。　　针对上述传闻，7月23日，迈瑞医疗回应媒体称：“以官方发布的信息为准”，未予置评。　　薪酬方面，迈瑞医疗2024年年度报告显示，其去年董监高薪酬合计高达1.39亿元，其中董事长李西廷薪酬为2493.9万元，董秘李文楣薪酬为738.76万元。","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"300760":"迈瑞医疗","LU1023057109.AUD":"BGF CHINA \"A2\" (AUDHDG) ACC","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","LU1688375341.USD":"贝莱德中国灵活股票基金","LU0572944931.SGD":"Janus Henderson Horizon China Opportunities A2 SGD","IE0005HP3H50.USD":"GUINNESS CHINA \"C\" (USD) ACC","LU0359202008.SGD":"Blackrock China Fund A2 SGD-H","LU1820825898.SGD":"Aberdeen Standard SICAV I - China A Share Equity A Acc SGD-H","LU0594300419.USD":"富达中国消费基金A","LU0405327148.USD":"ALLSPRING CHINA A FOCUS \"A\" (USD) ACC","LU2153592121.USD":"Aberdeen Standard SICAV I - Emerging Markets Sustainable Development Equity A Acc USD","LU1794554557.SGD":"Allianz All China Equity AT Acc H2-SGD","LU1655091616.SGD":"JPMorgan Funds - China A-Share Opportunities A (acc) SGD","LU1997245094.SGD":"安联神州A股基金AT Acc SGD","LU0359201612.USD":"贝莱德中国基金A2","LU1580142542.USD":"Blackrock Systematic China A-Share Opportunities A2 USD","LU1064131003.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"A\" (USD) ACC","IE0031814852.USD":"FSSA GREATER CHINA GROWTH \"I\" (USD) ACC","LU1934453819.USD":"AB CHINA A SHARES EQUITY PORTFOLIO \"A\" (USD) ACC","LU1146622755.USD":"安本中国A股股票基金A Acc","SGXZ81163826.USD":"UNITED CHINA A-SHARES INNOVATION \"A\" (USD) ACC","LU2348773727.SGD":"Aberdeen Standard SICAV I - Asian Sustainable Development Equity A Acc SGD-H","LU1734074674.USD":"NINETY ONE GSF ASIA PACIFIC FRANCHISE \"A\"(USD) ACC","SGXZ49509284.SGD":"United China A Shares Innovation A Acc SGD","LU0405327494.USD":"ALLSPRING CHINA A FOCUS \"I\" (USD) ACC","LU2213484517.USD":"FRANKLIN TEMPLETON CHINA A-SHARES \"A\" (USD) ACC","LU0327786744.USD":"Janus Henderson Horizon China Opportunities A2 USD","LU2424517915.HKD":"abrdn SICAV I -  ASIAN SDG EQUITY \"A\" (HKD) ACC","LU0823426480.USD":"法巴中国股票经典Dis","LU2148510915.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"R\" (USD) ACC","LU0823426308.USD":"法巴中国股票基金","IE00B29SXG58.USD":"FSSA CHINA FOCUS \"I\" (USD) ACC","LU0084288322.USD":"Natixis Asia Equity RD USD","LU1979443071.USD":"AB CHINA A SHARES EQUITY PORTFOLIO \"AD\" (USDHDG) INC","LU2348774022.SGD":"Aberdeen Standard SICAV I - Emerging Markets Sustainable Development Equity A Acc SGD-H","IE00B031J352.USD":"FSSA GREATER CHINA GROWTH \"I\" (USD) INC","BK0251":"专用设备","LU1064130708.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"I\" (USD) ACC","IE0008368742.USD":"首域中国增长基金I Acc","LU1997245177.USD":"安联神洲A股基金","LU0605514214.HKD":"FIDELITY CHINA CONSUMER \"A\" (HKD) ACC","LU1781817850.SGD":"Blackrock Systematic China A-Share Opportunities A2 SGD-H","LU0650527681.SGD":"Fidelity China Consumer A-SGD","LU1720050803.USD":"安联全方位中国股票基金","LU0594300179.USD":"FIDELITY CHINA CONSUMER \"A\" (USD) ACC","IE00B031HY20.USD":"FSSA CHINA GROWTH \"I\" (USD) INC","LU2153591404.USD":"Aberdeen Standard SICAV I - Asian Sustainable Development Equity A Acc USD"},"translate_title":"Mindray Medical is rumored to plan to go public in Hong Kong for a secondary listing, and the post-80s board secretary Li Wenmei has a daily salary of nearly 30,000 yuan","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300760":1},"content_text":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 　　瑞财经 刘治颖\n　　据外媒引述知情人士消息，迈瑞医疗（SZ300760）正考虑在香港进行二次上市，预计募集资金规模至少10亿美元（约合78亿港元）。迈瑞医疗已与潜在顾问就股份发售事宜展开初步讨论，相关方案仍在审议阶段。\n　　针对上述传闻，7月23日，迈瑞医疗回应媒体称：“以官方发布的信息为准”，未予置评。\n　　迈瑞医疗成立于1999年，是一家医疗设备研发商，涵盖生命信息与支持、体外诊断、数字超声、医学影像四大领域，旗下包括麻醉机、心电与除颤、凝血检测系统、尿液检测系统、超声管理系统、数字X射线成像系统等产品。\n　　2024年，迈瑞医疗实现营业收入367.26亿元，同比增长5.14%；归母净利润116.68亿元，同比增长0.74%。2025年一季度，公司营收82.37亿元、同比下滑12.12%；归母净利润26.29亿元，同比下滑16.81%。\n\n　　（迈瑞医疗部分董监高薪酬）\n　　薪酬方面，迈瑞医疗2024年年度报告显示，其去年董监高薪酬合计高达1.39亿元，其中董事长李西廷薪酬为2493.9万元，董秘李文楣薪酬为738.76万元。若按2024年251个工作日计算，李文楣的日薪高达2.94万元，四舍五入后接近3万元，远超行业平均水平。\n\n　　拉长时间来看，2020年至2023年，李文楣薪酬分别为663.2万元、541.4万元、723.8万元及750.2万元。\n　　资料显示，李文楣，女，1980年出生，中国（香港）国籍。毕业于北京大学，社会学系学士。现任迈瑞医疗董事会秘书兼董事会办公室主任、资本市场总经理。\n　　李文楣自2007年起历任迈瑞国际投资者关系经理、投资者关系总监、财务管理部总监、副首席财务官、首席投资官兼战略发展部副总经理、战略发展部总经理等职务。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：常福强","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2555865730","isCrawlerRequest":true}